India’s fourth largest pathology player, Neuberg Diagnostics Private Limited, today announced
receipt of approval from the Indian Council of Medical Research for COVID-19 testing in the state
of Kerala. Neuberg was the first to receive approval for COVID-19 testing in Ahmedabad
(NeubergSupratech), Bangalore (Neuberg Anand), Chennai (Neuberg Ehrlich) and Pune (Neuberg
A.G Diagnostics).
With more than12,000 cases for the state, vis-à-vis a national count of more than 11,00,000 cases,
Kerala has been lauded for its management of the pandemic that has crippled both the world and
the Indian healthcare system, causing losses to the tune of INR 30.3 lakh crore to the national
economy, as per the SBI Ecowrap 2020 report.
Opining on the development, Ms Aishwarya Vasudevan, Group Chief Operating,Neuberg
Diagnostics Private Limited said, “As the coronavirus (COVID-19) continues to spread globally, India
finds itself between Stage 2 and Stage 3 of the disease spread.The State & Central Government is
taking the right measures to curtail its spread. At this point of time, it is Neuberg’s and the
healthcare fraternity’s duty to fight this pandemic, hand-in-hand with our policymakers and our
people at the forefront.” She adds, “This is our sixth lab to get ICMR approval for RT PCR testing in
the country and we have also set up a special support fund for the weaker sections of the society.
Through this, we will offer free of cost testing to people with a BPL ration card and appropriate
doctor prescriptions”.
Adding further,Ms Vasudevan said, “Neuberg Diagnostics in Kochi has already started collecting
COVID samples.The mandatory requirement is the Identity and Address proof,
Requisition/Prescription from Physician with their Medical registration number. We intend to adhere
to the regulated timeline of 24-48 hours for reports throughout Kerala. Reporting and sample
acceptance will be strictly in accordance with the ICMR guidelines.
The COVID-19 testing in Neuberg’s labs will follow guidelines by ICMR and other competent
government agencies. COVID–19 samples from hospitals, nursing homes, and other healthcare
providers can be tested in the labs. If the patient has no travel history but is in the hospital with
symptoms of respiratory illness like pneumonia, she or he can also be tested.
As per the guidelines issued by ICMR for COVID-19 testing in private laboratories, Neuberg will
provide the test to an individual only when prescribed by a qualified physician, while also adhering
to the sample collection and testing guidelines set by ICMR.
For more details on COVID-19 testing at Neuberg, one may reach out to Neuberg Diagnostics at +91
97003 69700 or
Best-in-class laboratories across India, USA, UAE & South Africa have united under the banner of
Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing


countries. Utilizing their combined strengths, the Neuberg Alliance brings
capabilities to perform over

6000 varieties of Pathological investigations and will promote Prevention & Early Diagnosis, Focused
Wellness Programs and Structured Disease Management programs for rare diseases using the most
advanced technologies assisted by Data science and AI tools.
Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest
growing healthcare start-up in India. The founding members of the Neuberg consortium – Anand
Diagnostic Laboratory (Bangalore), SupratechMicropath (Ahmedabad), Ehrlich Laboratory (Chennai),
Global Labs (South Africa), and Minerva Diagnostics (Dubai) bring their combined heritage of over
200 years, and process over 20 million tests annually. Some of the best Pathologists, Biochemists,
Geneticists, Microbiologists and several other Clinical Lab Professionals from around the world are
working closely, sharing knowledge and using the latest generation of diagnostics techniques to take
accurate and timely diagnosis to the next level.
Kishor Barua// Krishna Kanhaiya Thakur
One Source // Neuberg Diagnostics
M:+91 95941 60314 // +91 91676 26757

Local AD

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More